Quality Improvement In Neurology Muscular Dystrophy Quality Measures

The muscular dystrophies (MDs) are a heterogeneous group of genetically determined myopathies. Identification of underlying genetic defects has demonstrated that MDs exhibit significant phenotypic and genetic heterogeneity. One genetic mutation can lead to a variety of phenotypes while different genetic mutations can manifest similar phenotypes; therefore MDs are challenging to diagnose. The authors thank the Muscular Dystrophy Quality Measurement Set Work Group members for their dedication, time, energy, contributions, and work that supported the development of this article: John D. England, MD, FAAN (American Academy of Neurology), Pushpa Narayanaswami, MBBS, DM, FAAN (American Academy of Neurology), Paula Clemens, MD (American Academy of Neurology), William S. David, MD, PhD, FAAN (American Academy of Neurology), Gary Gronseth, MD, FAAN (American Academy of Neurology), Carla Grosmann, MD (American Academy of Neurology), Michelle Mellion, MD (American Academy of Neurology), Jonathan Strober, MD (American Academy of Neurology), Benn Smith, MD, FAAN (American Association of Neuromuscular and Electrodiagnostic Medicine), Roxanna Bendixen, PhD, OTR (American Occupational Therapy Association), Frederic Shapiro, MD (American Academy of Orthopedic Surgeons), Jianguo Cheng, MD, PhD (American Academy of Pain Medicine), Robert Rinaldi, MD (American Academy of Physical Medicine and Rehabilitation), Christopher Spurney, MD (American College of Cardiology), Shreedevi Pandya, PT, DPT, MS (American Physical Therapy Association), Jonathan Finder, MD (American Thoracic Society), Ryan Coates, MD (Child Neurology Society), Jodi Wolff, PhD, MSSW (Muscular Dystrophy Association), Meganne Leach, MSN, APRN, PNP-BC (Cure CMD), Frank Lefevre, MD (Blue Cross Blue Shield), Richard Dubinsky, MD, MPH, FAAN (American Academy of Neurology Facilitator), David Wang, DO, FAHA, FAAN (American Academy of Neurology Facilitator), Gina Gjorvad (American Academy of Neurology Staff), Becky Schierman, MPH (American Academy of Neurology Staff), Rebecca Swain-Eng, MS, CAE (former American Academy of Neurology staff).